➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Mallinckrodt
Baxter
Merck
Harvard Business School

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

AMINOPHYLLINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Aminophylline, and when can generic versions of Aminophylline launch?

Aminophylline is a drug marketed by Abraxis Pharm, Am Regent, Elkins Sinn, Hospira, Intl Medication, King Pharms, Luitpold, Lyphomed, Pharma Serve Ny, Smith And Nephew, Teva Parenteral, Morton Grove, Roxane, Impax Labs, Tablicaps, Vale, Ani Pharms Inc, Ascot, Barr, Duramed Pharms Barr, Halsey, Hikma Intl Pharms, Kv Pharm, Lannett, Pal Pak, Panray, Purepac Pharm, Valeant Pharm Intl, Vangard, Vintage Pharms, Watson Labs, and Actavis Mid Atlantic. and is included in fifty-eight NDAs.

The generic ingredient in AMINOPHYLLINE is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminophylline

A generic version of AMINOPHYLLINE was approved as aminophylline by HOSPIRA on October 26th, 1983.

  Get Started for $10

Drug patent expirations by year for AMINOPHYLLINE
Recent Clinical Trials for AMINOPHYLLINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beni-Suef UniversityPhase 1
Wuhan Union Hospital, ChinaPhase 4
Le Bonheur Children's HospitalPhase 3

See all AMINOPHYLLINE clinical trials

Pharmacology for AMINOPHYLLINE
Drug ClassMethylxanthine

US Patents and Regulatory Information for AMINOPHYLLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm AMINOPHYLLINE aminophylline TABLET;ORAL 085284-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Barr AMINOPHYLLINE aminophylline TABLET;ORAL 088297-001 Aug 19, 1983 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Purepac Pharm AMINOPHYLLINE aminophylline TABLET;ORAL 085333-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.